Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Sujata PatilRobert J Motzer

Abstract

Analysis of prognostic factors for progression-free survival (PFS) and overall survival (OS) was performed using final data from a randomized phase III trial of sunitinib versus interferon-α (IFN-α) as first-line metastatic renal cell carcinoma (RCC) therapy. A multivariate Cox regression model analyzed baseline variables for prognostic significance. Each variable was investigated univariately and then multivariately using a stepwise algorithm. Each treatment arm comprised 375 patients. For sunitinib, multivariate analysis of PFS identified five independent predictors, including serum lactate dehydrogenase (LDH) level, presence of ≥2 metastatic sites, no prior nephrectomy, Eastern Cooperative Oncology Group (ECOG) performance status, and baseline platelet count, while multivariate analysis of OS identified serum LDH level, corrected serum calcium level, time from diagnosis to treatment, hemoglobin level, ECOG performance status, and presence of bone metastasis as predictors. For IFN-α, LDH level and presence of ≥2 metastatic sites were common predictors of PFS to those for sunitinib, as were all predictors of OS except ECOG status. This analysis identified prognostic factors for PFS and OS with sunitinib as first-line metastati...Continue Reading

References

Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerMadhu Mazumdar
Feb 6, 2003·British Journal of Cancer·J AtzpodienUNKNOWN DGCIN -- German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tarek M MekhailRonald Bukowski
Jan 12, 2007·The New England Journal of Medicine·Robert J MotzerRobert A Figlin
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Sep 27, 2008·L'Encéphale·P Chevallier
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerRobert A Figlin
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel Y C HengToni K Choueiri
Nov 7, 2009·Clinical Genitourinary Cancer·Ana M Molina, Robert J Motzer

❮ Previous
Next ❯

Citations

Apr 7, 2010·World Journal of Urology·Alessandro Volpe, Jean Jacques Patard
Mar 3, 2011·Clinical & Experimental Metastasis·Takeshi YuasaIwao Fukui
Apr 11, 2013·Drugs·Bernard EscudierGuru Sonpavde
Mar 31, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S T Tagawa
Nov 17, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Emily B SouthardRobin Taylor Wilson
Aug 11, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Judith ManolaUNKNOWN International Kidney Cancer Working Group
Oct 2, 2012·Journal of Neurosurgery. Spine·Ehsan H BalagamwalaSamuel T Chao
Nov 15, 2012·Pharmacogenomics·Cristina Rodríguez-Antona, Jesús García-Donas
Apr 20, 2014·World Journal of Urology·Dae Y KimChristopher G Wood
Apr 26, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M A ClimentJ Puente
Mar 13, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Daniel KeizmanRaanan Berger
Jul 19, 2011·Hematology/oncology Clinics of North America·Patricia A TangDaniel Y C Heng
Nov 29, 2015·The Urologic Clinics of North America·Andrew G WinerA Ari Hakimi
Mar 29, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Yoshihiro WadaMasatoshi Eto
Jun 2, 2011·Internal Medicine Journal·K WebberD Goldstein
Oct 12, 2013·International Journal of Cancer. Journal International Du Cancer·Matteo SantoniStefano Cascinu
Sep 12, 2015·Urologic Oncology·Haoran LiDaniel Y C Heng
Oct 12, 2014·Targeted Oncology·Katerina KubackovaUNKNOWN Czech Renal Cancer Cooperative Group
Apr 20, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·YanHong YaoBaoGuo Li
Nov 22, 2011·Expert Opinion on Pharmacotherapy·Shilpa Gupta, Mayer Fishman
Dec 3, 2014·The Lancet Oncology·Saeed DabestaniAxel Bex
Apr 6, 2011·Orvosi hetilap·Anikó Maráz
Sep 21, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A M MolinaR J Motzer
May 24, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Daniel KeizmanMichael A Carducci
Mar 14, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Daniel KeizmanMichael A Carducci
Oct 25, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Daniel KeizmanMichael A Carducci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Robert J MotzerRobert A Figlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Robert J MotzerMadhu Mazumdar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Robert J MotzerRobert A Figlin
© 2021 Meta ULC. All rights reserved